Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Pérez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavaldá J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Barranco JL, Peghin M, Roca C, Lara R, Cordero E, Influenza Vaccine in Solid Organ Transplant Recipient Study Group, Spanish Netwo.
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 21(11): . Nº de citas: 22
-
Martínez-Bonet M, Clemente MI, Álvarez S, Díaz L, García-Alonso D, Muñoz E, Moreno S, Muñoz-Fernández MÁ.
Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal
ANTIVIRAL RESEARCH . 123: 163-171. Nº de citas: 9
-
Pérez-Molina JA, Perez AM, Norman FF, Monge-Maillo B, López-Vélez R.
Old and new challenges in Chagas disease
LANCET INFECTIOUS DISEASES . 15(11): 1347-1356. Nº de citas: 60
-
San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network, Spain.
Effect of delaying prophylaxis against CMV in D plus /R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease
JOURNAL OF INFECTION . 71(5): 561-570. Nº de citas: 8
-
Casado JL, Esteban MA, Bañón S, Moreno A, Perez-Elías MJ, Mateos ML, Moreno S, Quereda C.
Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response
DIGESTIVE DISEASES AND SCIENCES . 60(11): 3473-3481. Nº de citas: 11
-
Cuervo G, Camoez M, Shaw E, Dominguez MÁ, Gasch O, Padilla B, Pintado V, Almirante B, Molina J, López-Medrano F, Ruiz de Gopegui E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MÁ, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients
BMC INFECTIOUS DISEASES . 15(1): 484-484. Nº de citas: 3
-
Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V.
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice
AIDS . 29(16): 2155-2159. Nº de citas: 3
-
Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano V.
The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain
AIDS REVIEWS . 17(4): 212-219. Nº de citas: 10
-
Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza E.
Current Epidemiology and Outcome of Infective Endocarditis A Multicenter, Prospective, Cohort Study
Medicine . 94(43): . Nº de citas: 76
-
Navas E, Torner N, Broner S, Godoy P, Martínez A, Bartolomé R, Domínguez A.
Economic costs of outbreaks of acute viral gastroenteritis due to norovirus in Catalonia (Spain), 2010-2011
Bmc Public Health . 15(1): 999-999. Nº de citas: 13
-
García Comas L, Ordobás Gavín M, Sanz Moreno JC, Ramos Blázquez B, Gutiérrez Rodríguez A, Astray Mochales J, Moreno Guillén S.
Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.
JOURNAL OF MEDICAL VIROLOGY . 87(10): 1697-1701. Nº de citas: 22
-
San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network.
Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D plus /R- solid organ transplant recipients
TRANSPLANT INFECTIOUS DISEASE . 17(5): 637-646. Nº de citas: 15
-
de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E.
Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century A Systematic Review of 111 Cases (2000-2013)
Medicine . 94(39): . Nº de citas: 33
-
Blanco JR, Arroyo-Manzano D, Rojas-Liévano JF, Crespo M, Bravo I, Pasquau J, Garcia Del Toro M, Herrero C, Rivero A, Moreno S, Llibre JM.
The Efficacy and Safety of Maraviroc Addition to a Stable Antiretroviral Regimen in Subjects with Suppressed Plasma HIV-RNA Is Not Influenced by Age
AIDS RESEARCH AND HUMAN RETROVIRUSES . 31(9): 893-897. Nº de citas: 4
-
Falcon A, Cuevas MT, Rodriguez-Frandsen A, Reyes N, Pozo F, Moreno S, Ledesma J, Martínez-Alarcón J, Nieto A, Casas I.
CCR5 deficiency predisposes to fatal outcome in influenza virus infection
JOURNAL OF GENERAL VIROLOGY . 96(8): 2074-2078. Nº de citas: 42
-
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration.
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study
The lancet. HIV . 2(8): 335-343. Nº de citas: 37
-
Llibre JM, Rivero A, Rojas JF, Garcia Del Toro M, Herrero C, Arroyo D, Pineda JA, Pasquau J, Masiá M, Crespo M, Blanco JR, Moreno S.
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes
ANTIVIRAL RESEARCH . 120: 79-84. Nº de citas: 11
-
Díaz L, Martínez-Bonet M, Sánchez J, Fernández-Pineda A, Jiménez JL, Muñoz E, Moreno S, Álvarez S, Muñoz-Fernández MÁ.
Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kappa B-dependent mechanism
SCIENTIFIC REPORTS . 5: 12442-12442. Nº de citas: 44